Spyre’s SPY001 Delivers Strong Early Results in Ulcerative Colitis Trial – Shares Jump

Spyre drug SPY001 showed strong IBD results, improving symptoms and remission in trials, boosting shares and future outlook.

Spyre’s SPY001 Delivers Strong Early Results in Ulcerative Colitis Trial – Shares Jump
Credit: Spyre Therapeutics
Already have an account? Sign in.